Skip to main content
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.76
-0.05 (-0.30%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Theravance Biopharma Revenue

In the year 2025, Theravance Biopharma had annual revenue of $107.46M with 66.92% growth. Theravance Biopharma had revenue of $45.89M in the quarter ending December 31, 2025, with 144.70% growth.

Revenue (ttm)
$107.46M
Revenue Growth
+66.92%
P/S Ratio
8.03
Revenue / Employee
$1,194,044
Employees
90
Market Cap
863.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025107.46M43.08M66.92%
Dec 31, 202464.38M6.96M12.12%
Dec 31, 202357.42M6.08M11.84%
Dec 31, 202251.35M-3.97M-7.17%
Dec 31, 202155.31M-16.55M-23.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Phathom Pharmaceuticals 175.11M
Xencor 125.58M
MeiraGTx Holdings 81.39M
CytomX Therapeutics 76.20M
Janux Therapeutics 10.00M
Revenue Rankings

TBPH News

More News